Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...

Within the past few years, the FDA approved two groundbreaking drugs that in trials were shown to reduce brain plaque by 27% ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

Researchers used data from more than 92,000 people with type 2 diabetes. They found that two medications significantly ...

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...

Scientists say the map of a speck of a mouse's brain could be as transformative as the Human Genome Project. Here's what to ...

This study suggests that regularly consuming kefir may be beneficial for slowing Alzheimer’s disease. Kefir is a versatile ...

Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but ...